Redox-Responsive Nanoparticles from the Single Disulfide Bond-Bridged Block Copolymer as Drug Carriers for Overcoming Multidrug Resistance in Cancer Cells-Reference-Cited by-同舟云学术

Redox-Responsive Nanoparticles from the Single Disulfide Bond-Bridged Block Copolymer as Drug Carriers for Overcoming Multidrug Resistance in Cancer Cells

Published:2011-09-09 Issue:10 Volume:22 Page:1939-1945
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Wang Yu-Cai¹,Wang Feng,Sun Tian-Meng,Wang Jun

Affiliation:

1. Department of Polymer Science and Engineering, University of Science and Technology of China, Hefei, Anhui 230026, P.R. China

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc200139n

Reference37 articles.

1. ABC Efflux Pump-Based Resistance to Chemotherapy Drugs

2. Microtubules and resistance to tubulin-binding agents

3. Why does cytotoxic chemotherapy cure only some cancers?

4. ABC transporters in cancer: more than just drug efflux pumps

5. ABCG2: A perspective

Cited by 254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A size shrinkable dendrimer-lipid hybrid nanoassembly for reversing tumor drug resistance;Green Chemical Engineering;2024-05

2. Polyethylene Glycol–Based Polymer-Drug Conjugates: Novel Design and Synthesis Strategies for Enhanced Therapeutic Efficacy and Targeted Drug Delivery;Applied Biochemistry and Biotechnology;2024-03-23

3. Study the anticancer efficacy of doxorubicin-loaded redox-responsive chitosan-derived nanoparticles in the MDA-MB-231 cell line;Carbohydrate Research;2024-02

4. GSH/pH dual responsive chitosan nanoparticles for reprogramming M2 macrophages and overcoming cancer chemoresistance;Biomaterials Science;2024

5. Development and evaluation of redox-responsive alginate–SS–ibuprofen derivative based anti-tumor target drug delivery system for the controlled release of doxorubicin;Journal of Drug Delivery Science and Technology;2024-01